Dong, B., Singh, A. B., Kelvin Kan, C. F., & Liu, J. (2014). CETP inhibitors downregulate hepatic LDL receptor and PCSK9 expression in vitro and in vivo through a SREBP2 dependent mechanism. Atherosclerosis.
Chicago-стиль цитированияDong, Bin, Amar Bahadur Singh, Chin Fung Kelvin Kan, and Jingwen Liu. "CETP Inhibitors Downregulate Hepatic LDL Receptor and PCSK9 Expression in Vitro and in Vivo Through a SREBP2 Dependent Mechanism." Atherosclerosis 2014.
MLA-цитированиеDong, Bin, Amar Bahadur Singh, Chin Fung Kelvin Kan, and Jingwen Liu. "CETP Inhibitors Downregulate Hepatic LDL Receptor and PCSK9 Expression in Vitro and in Vivo Through a SREBP2 Dependent Mechanism." Atherosclerosis 2014.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.